Humana Expands Board, Elects Robert Field as Director

Humana ( (HUM) ) has shared an announcement.

On April 10, 2026, Humana Inc.’s Board of Directors expanded its size from ten to eleven members and elected Robert S. Field as an independent director, with his appointment to take effect immediately following the company’s 2026 Annual Meeting of Stockholders on April 16, 2026. Field will receive compensation under Humana’s standard director program, including restricted stock units, and there are currently no related-party transactions or special arrangements tied to his election.

Field is Principal and Managing Member of ηMed Capital Management, an investment firm focused on U.S. healthcare services and managed care, and he brings more than two decades of healthcare investing experience, including roles at Luxor Capital, McKinsey & Company and Vinson & Elkins LLP. Humana’s chairman highlighted that Field’s expertise in investment evaluation, risk oversight, capital allocation and healthcare legal and regulatory dynamics is expected to strengthen the board as the company executes its growth strategy, with his selection following a comprehensive, shareholder-informed search process underscoring Humana’s emphasis on board refreshment and corporate governance.

The most recent analyst rating on (HUM) stock is a Buy with a $211.00 price target. To see the full list of analyst forecasts on Humana stock, see the HUM Stock Forecast page.

Spark’s Take on HUM Stock

According to Spark, TipRanks’ AI Analyst, HUM is a Neutral.

The score is held back primarily by weakened profitability and a sharp drop in recent free cash flow, reinforced by cautious 2026 guidance tied to the ~$3.5B STARS headwind and near-term MA margin pressure. Technicals are mixed (short-term improvement but longer-term downtrend), and valuation is only moderately supportive given the earnings reset.

To see Spark’s full report on HUM stock, click here.

More about Humana

Humana Inc. is a leading U.S. healthcare company that operates through its Humana insurance services and CenterWell healthcare services, aiming to make it easier for millions of people to achieve their best health. The company delivers care and services to people with Medicare and Medicaid, as well as families, individuals, military service personnel and broader communities across the country.

Humana’s offerings span health insurance and direct healthcare services, positioning it as a major player in managed care and related healthcare delivery markets. Its strategy centers on improving quality of life while pursuing profitable, sustainable growth and long-term shareholder value in a highly regulated and competitive healthcare landscape.

Average Trading Volume: 2,160,730

Technical Sentiment Signal: Sell

Current Market Cap: $23.69B

For detailed information about HUM stock, go to TipRanks’ Stock Analysis page.